glp 1 prior authorization glp-1 criteria Sharing a chart from the next issue of Plain Medicine, my Administrative costs of prior authorizations
Description
(2022b, May 16)

"I didn't tell anybody at first

Protective and ameliorative effects on insulin resistance were also observed

Eli Lillys GLP-1 offering, tirzepatide, launched shortly after (as Mounjaro for T2D in 2022 and Zepbound for obesity in 2023), demonstrated greater HbA1c reduction and up to a 20% placebo-adjusted weight loss

Expected sales from 2020 vs 2024 of Ozempic (and other diabetes drugs): It's exploding
